Micrima Ltd.

Redefining Breast Cancer Diagnostics

At Micrima, we are transforming breast tissue analysis to empower earlier, more personalised breast cancer diagnosis. Our innovative Mi~Scan® technology uses safe, non-ionising radio waves and AI to measure breast tissue properties—quickly, safely, and without compression, in any location. Our Mi~Score® product takes Mi~Scan® data and produces breast density maps, trending and direct integration with existing breast cancer risk models.  By delivering immediate insights into breast density and tissue type, we enable tailored diagnostic pathways and enhanced risk profiling for women of all ages. Our mission is to make advanced breast health data accessible to support informed, proactive care. With Micrima, clinicians gain vital tools to improve outcomes—and women gain the knowledge they need to take control of their breast health.

Visit us at stand 22.